Other

Tax Benefit of Reclassification for Sale of Securities

Humana Tax Benefit of Reclassification for Sale of Securities decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00.

Analysis

StatementIncome Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026Apr 29, 2026

How to read this metric

Fluctuations reflect changes in the tax burden associated with investment portfolio turnover.

Detailed definition

This reflects the income tax expense or benefit associated with the reclassification of realized gains or losses on secu...

Peer comparison

Commonly found in the tax reconciliation notes of financial institutions.

Metric ID: nee_tax_benefit_reclassification_sale_of_securities

Historical Data

12 periods
 Q3 '21Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$4.00M-$11.00M-$15.00M$1.00M$0.00$0.00$0.00$2.00M$1.00M$0.00$11.00M$0.00
QoQ Change-375.0%-36.4%+106.7%-100.0%-50.0%-100.0%-100.0%
YoY Change-375.0%+100.0%+100.0%-100.0%+450.0%-100.0%
Range-$15.00M$11.00M
CAGR-100.0%
Avg YoY Growth+12.5%
Median YoY Growth+0.0%

Frequently Asked Questions

What is Humana's tax benefit of reclassification for sale of securities?
Humana (HUM) reported tax benefit of reclassification for sale of securities of $0.00 in Q1 2026.
How has Humana's tax benefit of reclassification for sale of securities changed year-over-year?
Humana's tax benefit of reclassification for sale of securities decreased by 100.0% year-over-year, from $1.00M to $0.00.
What does tax benefit of reclassification for sale of securities mean?
The tax impact of reclassifying investment gains or losses into the income statement.